METLiT
Seoul, South Korea
METLiT can solve pharmaceutical companies' problem by providing customized MRS analysis solution with Deep learning. METLiT Specialized solution helps to determine the effectiveness of new drugs by acquiring information on direct metabolite changes in vivo, without relying on the patient's symptoms. Our solution provides quantitative and objective data to optimize clinical studies which helps to ascertain the most effective dosage and material of new drugs.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- metlit.ai/
Only accessible to MedStartr community members.
Join nowWhat do you think of METLiT?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now